Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies
- PMID: 26202661
- DOI: 10.1017/S0007114515002329
Tea consumption and mortality of all cancers, CVD and all causes: a meta-analysis of eighteen prospective cohort studies
Abstract
Epidemiological studies have demonstrated inconsistent associations between tea consumption and mortality of all cancers, CVD and all causes. To obtain quantitative overall estimates, we conducted a dose-response meta-analysis of prospective cohort studies. A literature search in PubMed and Embase up to April 2015 was conducted for all relevant papers published. Random-effects models were used to calculate pooled relative risks (RR) with 95 % CI. In eighteen prospective studies, there were 12 221, 11 306 and 55 528 deaths from all cancers, CVD and all causes, respectively. For all cancer mortality, the summary RR for the highest v. lowest category of green tea and black tea consumption were 1·06 (95 % CI 0·98, 1·15) and 0·79 (95 % CI 0·65, 0·97), respectively. For CVD mortality, the summary RR for the highest v. lowest category of green tea and black tea consumption were 0·67 (95 % CI 0·46, 0·96) and 0·88 (95 % CI 0·77, 1·01), respectively. For all-cause mortality, the summary RR for the highest v. lowest category of green tea and black tea consumption were 0·80 (95 % CI 0·68, 0·93) and 0·90 (95 % CI 0·83, 0·98), respectively. The dose-response analysis indicated that one cup per d increment of green tea consumption was associated with 5 % lower risk of CVD mortality and with 4 % lower risk of all-cause mortality. Green tea consumption was significantly inversely associated with CVD and all-cause mortality, whereas black tea consumption was significantly inversely associated with all cancer and all-cause mortality.
Keywords: All-cause mortality; CVD; Cancers; Meta-analyses; Mortality; Tea.
Similar articles
-
Green tea (Camellia sinensis) for the prevention of cancer.Cochrane Database Syst Rev. 2020 Mar 2;3(3):CD005004. doi: 10.1002/14651858.CD005004.pub3. Cochrane Database Syst Rev. 2020. PMID: 32118296 Free PMC article.
-
Dose-Response Relation between Tea Consumption and Risk of Cardiovascular Disease and All-Cause Mortality: A Systematic Review and Meta-Analysis of Population-Based Studies.Adv Nutr. 2020 Jul 1;11(4):790-814. doi: 10.1093/advances/nmaa010. Adv Nutr. 2020. PMID: 32073596 Free PMC article.
-
Green tea and liver cancer risk: A meta-analysis of prospective cohort studies in Asian populations.Nutrition. 2016 Jan;32(1):3-8. doi: 10.1016/j.nut.2015.05.021. Epub 2015 Jul 2. Nutrition. 2016. PMID: 26412579 Review.
-
Green tea, black tea consumption and risk of endometrial cancer: a systematic review and meta-analysis.Arch Gynecol Obstet. 2016 Jan;293(1):143-155. doi: 10.1007/s00404-015-3811-1. Epub 2015 Jul 3. Arch Gynecol Obstet. 2016. PMID: 26138307 Review.
-
Green tea, black tea consumption and risk of lung cancer: a meta-analysis.Lung Cancer. 2009 Sep;65(3):274-83. doi: 10.1016/j.lungcan.2008.12.002. Epub 2009 Jan 6. Lung Cancer. 2009. PMID: 19128856
Cited by
-
Beverages - a scoping review for Nordic Nutrition Recommendations 2023.Food Nutr Res. 2024 Apr 2;68. doi: 10.29219/fnr.v68.10458. eCollection 2024. Food Nutr Res. 2024. PMID: 38571923 Free PMC article. Review.
-
Association of tea and coffee consumption with the risk of all-cause and cause-specific mortality among individuals with metabolic syndrome: a prospective cohort study.Diabetol Metab Syndr. 2023 Nov 23;15(1):241. doi: 10.1186/s13098-023-01222-7. Diabetol Metab Syndr. 2023. PMID: 37993869 Free PMC article.
-
Supplements for Lipid Lowering: What Does the Evidence Show?Curr Cardiol Rep. 2023 Aug;25(8):795-805. doi: 10.1007/s11886-023-01903-9. Epub 2023 Jun 10. Curr Cardiol Rep. 2023. PMID: 37300664 Review.
-
Relationship between Coffee, Tea, and Carbonated Beverages and Cardiovascular Risk Factors.Nutrients. 2023 Feb 13;15(4):934. doi: 10.3390/nu15040934. Nutrients. 2023. PMID: 36839290 Free PMC article.
-
Mitochondrial Aging and Senolytic Natural Products with Protective Potential.Int J Mol Sci. 2022 Dec 19;23(24):16219. doi: 10.3390/ijms232416219. Int J Mol Sci. 2022. PMID: 36555859 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous